Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.


Journal

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
ISSN: 1827-675X
Titre abrégé: Acta Otorhinolaryngol Ital
Pays: Italy
ID NLM: 8213019

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 01 03 2022
accepted: 01 03 2022
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: ppublish

Résumé

This study aimed to evaluate the performance of the 2017 8 The cohort involved 300 patients affected by OTSCC treated with surgery. All cases were classified according to the 7 According to the 7 This study confirmed that the recent update of the 8th edition of the TNM (2020) improves stratification and identification of advanced tumours, reducing the number of T3 compared to the 2017 edition and increasing the number of patients with pT4. This improvement made by the updated edition may reduce the risk of skipping adjuvant therapy. Il carcinoma della lingua mobile: i cambiamenti della prognosi in base alla versione 2020 del sistema di classificazione AJCC/UICC TNM. Questo studio mira alla valutazione dell’efficacia predittiva dell’8ª edizione del TNM (2017) e dell’ultima versione aggiornata nel 2020 rispetto alla 7 Il gruppo di studio consta di 300 pazienti affetti da carcinoma spinocellulare della lingua mobile trattati chirurgicamente. Tutti i casi sono stati classificati in base alla 7 Secondo la 7 Questo studio ha confermato che il recente aggiornamento dell’8

Sections du résumé

Background UNASSIGNED
This study aimed to evaluate the performance of the 2017 8
Materials and methods UNASSIGNED
The cohort involved 300 patients affected by OTSCC treated with surgery. All cases were classified according to the 7
Results UNASSIGNED
According to the 7
Conclusions UNASSIGNED
This study confirmed that the recent update of the 8th edition of the TNM (2020) improves stratification and identification of advanced tumours, reducing the number of T3 compared to the 2017 edition and increasing the number of patients with pT4. This improvement made by the updated edition may reduce the risk of skipping adjuvant therapy.
Il carcinoma della lingua mobile: i cambiamenti della prognosi in base alla versione 2020 del sistema di classificazione AJCC/UICC TNM.
Obiettivo UNASSIGNED
Questo studio mira alla valutazione dell’efficacia predittiva dell’8ª edizione del TNM (2017) e dell’ultima versione aggiornata nel 2020 rispetto alla 7
Metodi UNASSIGNED
Il gruppo di studio consta di 300 pazienti affetti da carcinoma spinocellulare della lingua mobile trattati chirurgicamente. Tutti i casi sono stati classificati in base alla 7
Risultati UNASSIGNED
Secondo la 7
Conclusioni UNASSIGNED
Questo studio ha confermato che il recente aggiornamento dell’8

Autres résumés

Type: Publisher (ita)
Il carcinoma della lingua mobile: i cambiamenti della prognosi in base alla versione 2020 del sistema di classificazione AJCC/UICC TNM.

Identifiants

pubmed: 35612505
doi: 10.14639/0392-100X-N2055
pmc: PMC9131996
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-149

Informations de copyright

Copyright © 2022 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.

Références

J Cancer Res Ther. 2018 Jan;14(1):1-5
pubmed: 29516950
Head Neck. 2019 Aug;41(8):2756-2767
pubmed: 30942940
Head Neck Pathol. 2020 Jun;14(2):419-427
pubmed: 31230230
Oral Oncol. 2017 Aug;71:47-53
pubmed: 28688690
Int J Cancer. 2016 Aug 1;139(3):574-83
pubmed: 27038013
Swiss Med Wkly. 2021 May 02;151:w20493
pubmed: 33934314
Oral Oncol. 2020 Dec;111:104937
pubmed: 32750558
Oral Oncol. 2010 Sep;46(9):630-5
pubmed: 20637681
Cancers (Basel). 2021 Sep 28;13(19):
pubmed: 34638335
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
Head Neck. 2005 Dec;27(12):1080-91
pubmed: 16240329
Head Neck. 1997 May;19(3):205-10
pubmed: 9142520
Br J Oral Maxillofac Surg. 2018 Jan;56(1):8-13
pubmed: 29198482
Cancer Med. 2021 Apr;10(8):2566-2578
pubmed: 33760398
Curr Opin Otolaryngol Head Neck Surg. 2014 Apr;22(2):81-9
pubmed: 24504225
Front Oncol. 2021 Apr 12;11:616653
pubmed: 33912446
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Marta Tagliabue (M)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Rita De Berardinis (R)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Pietro Belloni (P)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Statistical Sciences, University of Padua, Padua, Italy.

Sara Gandini (S)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Donatella Scaglione (D)

Division of Data Management, European Institute of Oncology IRCCS, Milan, Italy.

Fausto Maffini (F)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Rosolino Antonino Mirabella (RA)

Department of Otorhinolaryngology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Stefano Riccio (S)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Giugliano Gioacchino (G)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Roberto Bruschini (R)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Francesco Chu (F)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Mohssen Ansarin (M)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH